Overview
Liver transplant failure encompasses both primary non-function and subsequent graft dysfunction, often complicated by rejection, which can severely impact patient outcomes. Simultaneous liver and kidney transplants present unique challenges in managing combined organ failure, necessitating careful patient selection and resource allocation 1.Diagnosis
Clinical Presentation: Signs of graft dysfunction including jaundice, ascites, encephalopathy, and elevated liver enzymes 1.
Imaging: Abdominal ultrasound or MRI to assess graft morphology and vascular patency 1.
Histopathology: Liver biopsy to evaluate for rejection (e.g., Banff scoring system) and other causes of failure 1.
Serum Biomarkers: Elevated levels of bilirubin, INR, and specific rejection markers like donor-specific antibodies 1.Management
Immunosuppression Adjustment: Tailor immunosuppressive regimens, often involving calcineurin inhibitors, mTOR inhibitors, or anti-thymocyte globulin for rejection 1.
Steroids: High-dose corticosteroids for acute rejection episodes 1.
Targeted Therapy: Use of monoclonal antibodies like basiliximab or daclizumab for antibody-mediated rejection 1.
Monitoring: Regular surveillance for signs of rejection and graft function through clinical assessment and laboratory tests 1.Special Populations
Combined Liver and Kidney Transplant: Careful patient selection crucial; consider reversibility of acute kidney injury and individual organ needs 1.
Complex Cases: Shared multicenter experiences and clinical trials needed for optimizing management in patients with combined liver and kidney dysfunction 1.Key Recommendations
Optimize patient selection for simultaneous liver and kidney transplants based on reversible conditions and individual organ needs (Evidence: Expert opinion) 1.
Employ liver biopsy and Banff scoring system for definitive diagnosis of rejection (Evidence: Moderate) 1.
Tailor immunosuppressive therapy based on rejection type, incorporating calcineurin inhibitors and targeted monoclonal antibodies as needed (Evidence: Moderate) 1.References
1 Chopra A, Cantarovich M, Bain VG. Simultaneous liver and kidney transplants: optimizing use of this double resource. Transplantation 2011. link